LEXARIA BIOSCIENCE CORP. Operating Lease, Expense
LEXARIA BIOSCIENCE CORP. (LEXX) reported Operating Lease, Expense of $1.90 thousand for the 9-month period ending 2021-05-31, per its 10-Q filed 2021-07-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2021-07-15
- LEXARIA BIOSCIENCE CORP. operating lease, expense for the quarter ending 2020-11-30 was $2.22K.
- LEXARIA BIOSCIENCE CORP. operating lease, expense for fiscal 2020 was $10.42K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|
| 2021-05-31 | $1.90K 10-Q · filed 2021-07-15 | ||
| 2020-11-30 | $2.22K 10-Q · filed 2021-01-14 | ||
| 2020-08-31 | $10.42K 10-K · filed 2020-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |